Hubei Xingfa Chemicals Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	3yrs
Board average tenure	3yrs

Recent management updates

Recent updates

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

Apr 05

CEO

Hubei Xingfa Chemicals Group has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Chen Wang	Deputy GM & CFO	no data	CN¥1.00m	0.018% CN¥ 4.3m
Jie Wang	Executive Deputy GM & Director	no data	CN¥1.05m	0.013% CN¥ 3.0m
Long Shu	MD & Director	no data	CN¥1.09m	0.016% CN¥ 3.7m
Boying Bao	Board Secretary	3yrs	CN¥783.00k	0.0082% CN¥ 1.9m
Xiao Shan Ni	Deputy General Manager	3yrs	CN¥1.08m	0.017% CN¥ 4.1m
Chang Liu	Deputy General Manager	3yrs	CN¥1.05m	0.011% CN¥ 2.7m
Yong Zhao	Deputy General Manager	3yrs	CN¥1.61m	0.011% CN¥ 2.5m
Tie Jun Yang	Deputy General Manager	3yrs	CN¥1.18m	0.013% CN¥ 3.1m
Mingqing Lu	Deputy General Manager	4.1yrs	CN¥1.13m	0.011% CN¥ 2.5m
Qiao Zhang	Deputy General Manager	1.3yrs	no data	0.0067% CN¥ 1.6m

3.0yrs

Average Tenure

46.5yo

Average Age

Experienced Management: 600141's management team is considered experienced (3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jie Wang	Executive Deputy GM & Director	3yrs	CN¥1.05m	0.013% CN¥ 3.0m
Long Shu	MD & Director	no data	CN¥1.09m	0.016% CN¥ 3.7m
Guozhang Li	Chairman	no data	CN¥540.00k	0.023% CN¥ 5.4m
Liu Zhong Hua	Independent Director	3yrs	CN¥155.00k	no data
Ya Li Cheng	Director	no data	CN¥60.00k	0.011% CN¥ 2.5m
Kun Yi Hu	Vice Chairman	no data	CN¥1.06m	0.012% CN¥ 3.0m
Daqiao Cui	Independent Director	no data	CN¥155.00k	no data
Xiao Yan Zhang	Independent director	no data	CN¥155.00k	no data
Bing Yuan	Director	3yrs	CN¥60.00k	0.014% CN¥ 3.3m
Chunqian Jiang	Independent Director	3yrs	CN¥155.00k	no data
Xianjun Cao	Independent Director	3yrs	CN¥155.00k	no data
Dongfeng Xue	Independent Director	2.1yrs	CN¥105.00k	no data

3.0yrs

Average Tenure

56yo

Average Age

Experienced Board: 600141's board of directors are considered experienced (3 years average tenure).

Hubei Xingfa Chemicals Group Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.40 in 1Q 2023)

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

New major risk - Financial position

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 16%

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

Hubei Xingfa Chemicals' Controlling Shareholder Plans to Raise its Holdings in the Company

Consensus EPS estimates fall by 43%

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

New minor risk - Profit margin trend

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q2, 2023 Results on Aug 21, 2023

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Price target decreased to CN¥45.75

Third quarter 2022 earnings released: EPS: CN¥1.17 (vs CN¥1.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.70 in 2Q 2021)

Price target increased to CN¥51.33

Investor sentiment deteriorated over the past week

Price target increased to CN¥49.56

Investor sentiment improved over the past week

Price target increased to CN¥45.41

Investor sentiment improved over the past week

Consensus EPS estimates increase by 14%

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Price target increased to CN¥44.89

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.10 (vs CN¥0.22 in 3Q 2020)

Investor sentiment deteriorated over the past week

Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) signed an Equity Purchase Agreement to acquire additional 18.785% minority stake in Hubei Taisheng Chemical Co., Ltd. from ABC Financial Asset Investment Co., Ltd. for approximately CNY 510 million.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Consensus EPS estimates increase to CN¥1.66

Second quarter 2021 earnings released: EPS CN¥0.70 (vs CN¥0.14 in 2Q 2020)

Consensus forecasts updated

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.02 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.33 in FY 2019)

New 90-day high: CN¥14.78

New 90-day high: CN¥13.77

New 90-day high: CN¥12.40

Third quarter earnings released

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020

Analysts lower EPS estimates to CN¥0.35

Earnings released

New 90-day high - CN¥11.85

New 90-day high - CN¥10.59

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age